Here’s a structured FAQ collection for researchers working with the At1g11280 antibody, optimized for academic research scenarios and informed by computational antibody design principles, experimental validation methodologies, and protein interaction studies:
Employ conditional knockdown/knockout systems (e.g., ethanol-inducible RNAi) to avoid developmental pleiotropy.
Combine antibody-based detection with orthogonal methods (e.g., RT-qPCR for transcript levels, LC-MS/MS for protein quantification).
For ChIP-seq experiments, use isotype-matched IgG controls and spike-in Arabidopsis chromatin with human chromatin to normalize background signals .
Verify antibody batches via parallel testing on validated positive/negative samples.
Assess fixation artifacts by comparing chemical fixation (formaldehyde) vs. cryofixation results.
Perform subcellular fractionation with antibody probing across nuclear/cytosolic/membrane fractions.
| Common Pitfall | Resolution Strategy |
|---|---|
| Cross-reactive epitopes | Epitope truncation assays |
| Fixation-induced epitope masking | Alternative fixation protocols |
| Post-translational modifications | Phosphatase/protease treatments |
Use RosettaAntibodyDesign to model CDR loops and predict paratope-epitope interactions.
Perform molecular dynamics simulations (≥100 ns) to assess binding stability under physiological conditions.
Validate in silico predictions via alanine scanning mutagenesis of predicted hotspot residues .
ΔΔG binding energy ≤ -7 kcal/mol (strong binder threshold)
Solvent-accessible surface area (SASA) ≤ 800 Ų for epitope region
Co-IP/MS: Use mild crosslinkers (DSS) to preserve transient interactions in floral bud lysates.
BioID proximity labeling: Express At1g11280-BirA* fusion protein under native promoter.
Data integration: Apply STRING database (association score >0.7) and Gene Ontology enrichment (FDR ≤0.05) .
| Interactome Confidence Level | Validation Requirement |
|---|---|
| High (≥5 prey proteins) | Reciprocal co-IP + bimolecular fluorescence complementation |
| Medium (3-4 prey proteins) | Yeast two-hybrid confirmation |
Apply mixed-effects models to account for batch effects across biological replicates.
Use ANOVA with Tukey’s HSD for multi-tissue expression comparisons.
For low-abundance samples, implement stochastic normalization (e.g., SCAN algorithm) on microarray/RNA-seq data .
Coefficient of variation <15% for technical replicates
≥3 biological replicates with non-overlapping cultivation dates